RLX TECHNOLOGY INC-ADR (RLX)

US74969N1037 - ADR

1.99  -0.06 (-2.93%)

Fundamental Rating

5

Taking everything into account, RLX scores 5 out of 10 in our fundamental rating. RLX was compared to 10 industry peers in the Tobacco industry. RLX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. RLX is valied quite expensively at the moment, while it does show a decent growth rate.



4

1. Profitability

1.1 Basic Checks

In the past year RLX was profitable.
In the past year RLX had a positive cash flow from operations.
Of the past 5 years RLX 4 years were profitable.
Each year in the past 5 years RLX had a positive operating cash flow.

1.2 Ratios

RLX has a Return On Assets (3.27%) which is in line with its industry peers.
The Return On Equity of RLX (3.42%) is better than 80.00% of its industry peers.
Industry RankSector Rank
ROA 3.27%
ROE 3.42%
ROIC N/A
ROA(3y)8.15%
ROA(5y)4.92%
ROE(3y)9.22%
ROE(5y)12.83%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of RLX (33.68%) is better than 90.00% of its industry peers.
RLX has a Gross Margin (24.44%) which is in line with its industry peers.
RLX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 33.68%
GM 24.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.14%
GM growth 5Y-11.35%

9

2. Health

2.1 Basic Checks

RLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RLX remains at a similar level compared to 1 year ago.
Compared to 5 years ago, RLX has less shares outstanding
The debt/assets ratio for RLX is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 20.67 indicates that RLX is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 20.67, RLX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
RLX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.56
Altman-Z 20.67
ROIC/WACCN/A
WACC7.51%

2.3 Liquidity

A Current Ratio of 13.44 indicates that RLX has no problem at all paying its short term obligations.
With an excellent Current ratio value of 13.44, RLX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
RLX has a Quick Ratio of 13.22. This indicates that RLX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 13.22, RLX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.44
Quick Ratio 13.22

6

3. Growth

3.1 Past

The earnings per share for RLX have decreased strongly by -62.54% in the last year.
Looking at the last year, RLX shows a very negative growth in Revenue. The Revenue has decreased by -70.25% in the last year.
RLX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 64.28% yearly.
EPS 1Y (TTM)-62.54%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q190.88%
Revenue 1Y (TTM)-70.25%
Revenue growth 3Y-25.39%
Revenue growth 5Y64.28%
Revenue growth Q2Q73.92%

3.2 Future

Based on estimates for the next years, RLX will show a very strong growth in Earnings Per Share. The EPS will grow by 30.89% on average per year.
Based on estimates for the next years, RLX will show a very strong growth in Revenue. The Revenue will grow by 44.13% on average per year.
EPS Next Y58.29%
EPS Next 2Y38.86%
EPS Next 3Y30.89%
EPS Next 5YN/A
Revenue Next Year72.2%
Revenue Next 2Y59.23%
Revenue Next 3Y44.13%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 39.80, the valuation of RLX can be described as expensive.
Based on the Price/Earnings ratio, RLX is valued a bit more expensive than 60.00% of the companies in the same industry.
RLX is valuated rather expensively when we compare the Price/Earnings ratio to 28.02, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 20.51, the valuation of RLX can be described as rather expensive.
60.00% of the companies in the same industry are cheaper than RLX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of RLX to the average of the S&P500 Index (20.58), we can say RLX is valued inline with the index average.
Industry RankSector Rank
PE 39.8
Fwd PE 20.51

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, RLX is valued a bit more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 135.47
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as RLX's earnings are expected to grow with 30.89% in the coming years.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y38.86%
EPS Next 3Y30.89%

1

5. Dividend

5.1 Amount

RLX has a yearly dividend return of 0.40%, which is pretty low.
RLX's Dividend Yield is slightly below the industry average, which is at 5.67.
With a Dividend Yield of 0.40, RLX pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.4%

5.2 History

RLX is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

RLX pays out 17.29% of its income as dividend. This is a sustainable payout ratio.
DP17.29%
EPS Next 2Y38.86%
EPS Next 3Y30.89%

RLX TECHNOLOGY INC-ADR

NYSE:RLX (5/7/2024, 2:12:05 PM)

1.99

-0.06 (-2.93%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.13B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.4%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 39.8
Fwd PE 20.51
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.27%
ROE 3.42%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 33.68%
GM 24.44%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 13.44
Quick Ratio 13.22
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-62.54%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y58.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-70.25%
Revenue growth 3Y-25.39%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y